Definition of in vitro model systems in which non MHC-restricted cytotoxic cells are generated under conditions of lymphocytes' stimulation constitutes an essential tool for the understanding of the lineage and biology of the cytotoxic cells, of the factors regulating their proliferation and activation, and of the interplay occurring in vivo in pathological situations among different cell types effector of the immune and non immune system. We developed an in vitro system in which high numbers of cytotoxic cells are generated, depending on endogenous IL-2 production, from peripheral blood mononuclear cells cocultured with B lymphoblastoid lines, even if these lack class I HLA antigens. Most, but not all, of these expanded cytotoxic lymphocytes have characteristics of NK cells. Moreover, we observed that B lymphoblastoid lines constitutively produce a factor that potentiates several functional properties of NK cells, among which are cytotoxic activity, production of lymphokines and proliferation. This factor is clearly distinct from other known lymphokines such as IL-2, interferon (IFN) or lymphotoxin (LT). It is our working hypothesis that, in vivo, proliferation, differentiation and functions of NK cells and of other non well defined cytotoxic cell types (among which possibly LAK cells) are regulated not only by IL-2, but also by other cytokines, possibly produced by accessory cells or by the NK cells themselves, upon cellular interaction or IL-2 stimulation. The system we developed and our observation that NKSF, a factor distinct from IL-2, activates NK cells offer the opportunity to study the regulation of NK cell activation and proliferation under conditions similar to those possibly present in pathological in vivo situations in which minimal antigenic differences may induce lymphocyte activation. The studies proposed to characterize our in vitro model and NKSF should provide information on NK cells' biology and on the practical possibility of enhancing efficiently their number and functions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA045284-03
Application #
3188373
Study Section
Experimental Immunology Study Section (EI)
Project Start
1987-07-01
Project End
1991-01-15
Budget Start
1990-01-01
Budget End
1991-01-15
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Loza, Matthew J; Metelitsa, Leonid S; Perussia, Bice (2002) NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production. Eur J Immunol 32:3453-62
Azzoni, L; Zatsepina, O; Abebe, B et al. (1998) Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol 161:3493-500
Bennett, I M; Zatsepina, O; Zamai, L et al. (1996) Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med 184:1845-56
Kanakaraj, P; Duckworth, B; Azzoni, L et al. (1994) Phosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-ligand interaction. J Exp Med 179:551-8
Hill, L L; Perussia, B; McCue, P A et al. (1994) Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency. Cancer Res 54:763-70
Anegon, I; Blottiere, H; Cuturi, M C et al. (1993) Characterization of a human monocyte antigen, B148.4, regulated during cell differentiation and activation. J Leukoc Biol 53:390-8
Salcedo, T W; Azzoni, L; Wolf, S F et al. (1993) Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol 151:2511-20
Zupo, S; Azzoni, L; Massara, R et al. (1993) Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes. J Clin Immunol 13:228-36
Salcedo, T W; Kurosaki, T; Kanakaraj, P et al. (1993) Physical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells. J Exp Med 177:1475-80
Perussia, B; Chan, S H; D'Andrea, A et al. (1992) Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol 149:3495-502

Showing the most recent 10 out of 16 publications